Nuclear Proteins and Regulation of Lymphocyte Growth

Feuerstein, Nili H.

Abstract

Funding Agency

• Agency: National Institute of Health (NIH)
• Institute: National Cancer Institute (NCI)
• Type: First Independent Research Support & Transition (FIRST) Awards (R29)
• Project #: 3R29CA048667-03S1
• Application #: 3459179
• Study Section: Cellular Biology and Physiology Subcommittee 1 (CBY)
• Project Start: 1988-12-01
• Project End: 1993-11-30
• Budget Start: 1989-12-01
• Budget End: 1990-11-30
• Support Year: 3
• Fiscal Year: 1990

Institution

• Name: University of Pennsylvania
• Type: Schools of Medicine
• DUNS #: 042250712
• City: Philadelphia
• State: PA
• Country: United States
• Zip Code: 19104

Publications

Feuerstein, N; Huang, D; Prystowsky, M B (1995) Rapamycin selectively blocks interleukin-2-induced proliferating cell nuclear antigen gene expression in T lymphocyte. Evidence for inhibition of CREB/ATF binding activities. J Biol Chem 270:9454-8

Feuerstein, N; Lindsberg, M L; Tung, L et al. (1991) Identification of a prominent 85-kDa cAMP-dependent phosphoprotein associated with late G1 phase in mitogen-stimulated B lymphocytes. J Biol Chem 266:4746-51

Mond, J J; Feuerstein, N; June, C H et al. (1991) Bimodal effect of phorbol ester on B cell activation. Implication for the role of protein kinase C. J Biol Chem 266:4458-63

Feuerstein, N; Randazzo, P A (1991) In vivo and in vitro phosphorylation studies of numatrin, a cell cycle regulated nuclear protein, in insulin-stimulated NIH 3T3 HIR cells. Exp Cell Res 194:289-96

Feuerstein, N; Mond, J J; Kinchington, P R et al. (1990) Evidence for DNA binding activity of numatrin (B23), a cell cycle-regulated nuclear matrix protein. Biochim Biophys Acta 1087:127-36